Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

985 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC.
Wu YL, John T, Grohe C, Majem M, Goldman JW, Kim SW, Kato T, Laktionov K, Vu HV, Wang Z, Lu S, Lee KY, Akewanlop C, Yu CJ, de Marinis F, Bonanno L, Domine M, Shepherd FA, Zeng L, Atasoy A, Herbst RS, Tsuboi M. Wu YL, et al. Among authors: tsuboi m. J Thorac Oncol. 2022 Mar;17(3):423-433. doi: 10.1016/j.jtho.2021.10.014. Epub 2021 Nov 2. J Thorac Oncol. 2022. PMID: 34740861 Free article. Clinical Trial.
A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H, Watanabe Y, Wada H, Tsuboi M, Hamajima N, Ohta M; Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy. Kato H, et al. Among authors: tsuboi m. N Engl J Med. 2004 Apr 22;350(17):1713-21. doi: 10.1056/NEJMoa032792. N Engl J Med. 2004. PMID: 15102997 Free article. Clinical Trial.
The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer.
Rami-Porta R, Ball D, Crowley J, Giroux DJ, Jett J, Travis WD, Tsuboi M, Vallières E, Goldstraw P; International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. Rami-Porta R, et al. Among authors: tsuboi m. J Thorac Oncol. 2007 Jul;2(7):593-602. doi: 10.1097/JTO.0b013e31807a2f81. J Thorac Oncol. 2007. PMID: 17607114 Free article.
The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer.
Rusch VW, Crowley J, Giroux DJ, Goldstraw P, Im JG, Tsuboi M, Tsuchiya R, Vansteenkiste J; International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. Rusch VW, et al. Among authors: tsuboi m. J Thorac Oncol. 2007 Jul;2(7):603-12. doi: 10.1097/JTO.0b013e31807ec803. J Thorac Oncol. 2007. PMID: 17607115 Free article.
Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study.
Kubota K, Kawahara M, Ogawara M, Nishiwaki Y, Komuta K, Minato K, Fujita Y, Teramukai S, Fukushima M, Furuse K; Japan Multi-National Trial Organisation. Kubota K, et al. Lancet Oncol. 2008 Dec;9(12):1135-42. doi: 10.1016/S1470-2045(08)70261-4. Epub 2008 Nov 13. Lancet Oncol. 2008. PMID: 19013107 Clinical Trial.
A phase I study of topotecan plus carboplatin for relapsed SCLC: WJTOG trial.
Kurata T, Kashii T, Takeda K, Seki N, Tsuboi M, Kobayashi M, Satoh T, Nakagawa K, Fukuoka M. Kurata T, et al. Among authors: tsuboi m. J Thorac Oncol. 2009 May;4(5):644-8. doi: 10.1097/JTO.0b013e31819f978a. J Thorac Oncol. 2009. PMID: 19325498 Free article. Clinical Trial.
985 results